nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—Bad taste—Donepezil—Alzheimer's disease	0.0202	0.053	CcSEcCtD
Nedocromil—HSP90AA1—blood vessel—Alzheimer's disease	0.0186	0.123	CbGeAlD
Nedocromil—FPR1—nervous system—Alzheimer's disease	0.0147	0.097	CbGeAlD
Nedocromil—FPR1—central nervous system—Alzheimer's disease	0.0141	0.0934	CbGeAlD
Nedocromil—PTGDR—nervous system—Alzheimer's disease	0.0139	0.0916	CbGeAlD
Nedocromil—Disorder sight—Galantamine—Alzheimer's disease	0.0138	0.0363	CcSEcCtD
Nedocromil—PTGDR—central nervous system—Alzheimer's disease	0.0133	0.0882	CbGeAlD
Nedocromil—HSP90AA1—embryo—Alzheimer's disease	0.0111	0.0733	CbGeAlD
Nedocromil—PTGDR—brain—Alzheimer's disease	0.0106	0.07	CbGeAlD
Nedocromil—HSP90AA1—forebrain—Alzheimer's disease	0.0098	0.0648	CbGeAlD
Nedocromil—Disorder sight—Memantine—Alzheimer's disease	0.00972	0.0255	CcSEcCtD
Nedocromil—Disorder sight—Rivastigmine—Alzheimer's disease	0.00951	0.025	CcSEcCtD
Nedocromil—HSP90AA1—telencephalon—Alzheimer's disease	0.00901	0.0596	CbGeAlD
Nedocromil—Otitis media—Donepezil—Alzheimer's disease	0.00655	0.0172	CcSEcCtD
Nedocromil—CYSLTR1—nervous system—Alzheimer's disease	0.00613	0.0405	CbGeAlD
Nedocromil—Rash erythematous—Memantine—Alzheimer's disease	0.00604	0.0159	CcSEcCtD
Nedocromil—Otitis media—Memantine—Alzheimer's disease	0.00595	0.0156	CcSEcCtD
Nedocromil—Rash erythematous—Rivastigmine—Alzheimer's disease	0.00591	0.0155	CcSEcCtD
Nedocromil—CYSLTR1—central nervous system—Alzheimer's disease	0.00591	0.039	CbGeAlD
Nedocromil—Otitis media—Rivastigmine—Alzheimer's disease	0.00582	0.0153	CcSEcCtD
Nedocromil—Stinging—Rivastigmine—Alzheimer's disease	0.00559	0.0147	CcSEcCtD
Nedocromil—Cough increased—Donepezil—Alzheimer's disease	0.00557	0.0146	CcSEcCtD
Nedocromil—Dysphonia—Rivastigmine—Alzheimer's disease	0.0055	0.0144	CcSEcCtD
Nedocromil—Gastroenteritis—Galantamine—Alzheimer's disease	0.00539	0.0141	CcSEcCtD
Nedocromil—HSP90AA1—nervous system—Alzheimer's disease	0.00532	0.0352	CbGeAlD
Nedocromil—HSP90AA1—central nervous system—Alzheimer's disease	0.00512	0.0339	CbGeAlD
Nedocromil—Viral infection—Rivastigmine—Alzheimer's disease	0.00501	0.0132	CcSEcCtD
Nedocromil—HSP90AA1—cerebellum—Alzheimer's disease	0.00501	0.0331	CbGeAlD
Nedocromil—Arthritis—Galantamine—Alzheimer's disease	0.00491	0.0129	CcSEcCtD
Nedocromil—CYSLTR1—brain—Alzheimer's disease	0.00469	0.031	CbGeAlD
Nedocromil—Ear pain—Donepezil—Alzheimer's disease	0.00434	0.0114	CcSEcCtD
Nedocromil—Gastroenteritis—Donepezil—Alzheimer's disease	0.00418	0.011	CcSEcCtD
Nedocromil—Eczema—Donepezil—Alzheimer's disease	0.00412	0.0108	CcSEcCtD
Nedocromil—HSP90AA1—brain—Alzheimer's disease	0.00407	0.0269	CbGeAlD
Nedocromil—Bronchitis—Galantamine—Alzheimer's disease	0.00397	0.0104	CcSEcCtD
Nedocromil—Ear pain—Memantine—Alzheimer's disease	0.00394	0.0103	CcSEcCtD
Nedocromil—Ear pain—Rivastigmine—Alzheimer's disease	0.00385	0.0101	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Galantamine—Alzheimer's disease	0.00384	0.0101	CcSEcCtD
Nedocromil—Arthritis—Donepezil—Alzheimer's disease	0.00381	0.00999	CcSEcCtD
Nedocromil—Gastroenteritis—Memantine—Alzheimer's disease	0.00379	0.00995	CcSEcCtD
Nedocromil—Eczema—Memantine—Alzheimer's disease	0.00374	0.00981	CcSEcCtD
Nedocromil—Gastroenteritis—Rivastigmine—Alzheimer's disease	0.00371	0.00973	CcSEcCtD
Nedocromil—Pneumonia—Galantamine—Alzheimer's disease	0.0037	0.00971	CcSEcCtD
Nedocromil—Eczema—Rivastigmine—Alzheimer's disease	0.00366	0.0096	CcSEcCtD
Nedocromil—Arthritis—Memantine—Alzheimer's disease	0.00346	0.00907	CcSEcCtD
Nedocromil—Arthritis—Rivastigmine—Alzheimer's disease	0.00338	0.00888	CcSEcCtD
Nedocromil—Rhinitis—Galantamine—Alzheimer's disease	0.00331	0.00869	CcSEcCtD
Nedocromil—Influenza—Donepezil—Alzheimer's disease	0.0032	0.0084	CcSEcCtD
Nedocromil—Visual impairment—Galantamine—Alzheimer's disease	0.00318	0.00836	CcSEcCtD
Nedocromil—Eosinophilia—Donepezil—Alzheimer's disease	0.00317	0.00831	CcSEcCtD
Nedocromil—Bronchitis—Donepezil—Alzheimer's disease	0.00308	0.00807	CcSEcCtD
Nedocromil—Influenza—Memantine—Alzheimer's disease	0.0029	0.00762	CcSEcCtD
Nedocromil—Pneumonia—Donepezil—Alzheimer's disease	0.00287	0.00753	CcSEcCtD
Nedocromil—Dysgeusia—Galantamine—Alzheimer's disease	0.00282	0.00739	CcSEcCtD
Nedocromil—Bronchitis—Memantine—Alzheimer's disease	0.00279	0.00733	CcSEcCtD
Nedocromil—Conjunctivitis—Donepezil—Alzheimer's disease	0.00277	0.00728	CcSEcCtD
Nedocromil—Bronchitis—Rivastigmine—Alzheimer's disease	0.00273	0.00717	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.0027	0.00708	CcSEcCtD
Nedocromil—Tremor—Galantamine—Alzheimer's disease	0.00269	0.00707	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.00264	0.00693	CcSEcCtD
Nedocromil—Pneumonia—Memantine—Alzheimer's disease	0.0026	0.00684	CcSEcCtD
Nedocromil—Rhinitis—Donepezil—Alzheimer's disease	0.00257	0.00674	CcSEcCtD
Nedocromil—Pneumonia—Rivastigmine—Alzheimer's disease	0.00255	0.00669	CcSEcCtD
Nedocromil—Pharyngitis—Donepezil—Alzheimer's disease	0.00254	0.00667	CcSEcCtD
Nedocromil—Conjunctivitis—Memantine—Alzheimer's disease	0.00252	0.00661	CcSEcCtD
Nedocromil—Cough—Galantamine—Alzheimer's disease	0.00251	0.00659	CcSEcCtD
Nedocromil—Visual impairment—Donepezil—Alzheimer's disease	0.00247	0.00648	CcSEcCtD
Nedocromil—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.00246	0.00646	CcSEcCtD
Nedocromil—Chest pain—Galantamine—Alzheimer's disease	0.00245	0.00643	CcSEcCtD
Nedocromil—Sinusitis—Memantine—Alzheimer's disease	0.00243	0.00638	CcSEcCtD
Nedocromil—Dry mouth—Galantamine—Alzheimer's disease	0.00239	0.00628	CcSEcCtD
Nedocromil—Sinusitis—Rivastigmine—Alzheimer's disease	0.00238	0.00624	CcSEcCtD
Nedocromil—Rhinitis—Memantine—Alzheimer's disease	0.00233	0.00612	CcSEcCtD
Nedocromil—Pharyngitis—Memantine—Alzheimer's disease	0.00231	0.00606	CcSEcCtD
Nedocromil—Rhinitis—Rivastigmine—Alzheimer's disease	0.00228	0.00598	CcSEcCtD
Nedocromil—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00226	0.00592	CcSEcCtD
Nedocromil—Visual impairment—Memantine—Alzheimer's disease	0.00224	0.00588	CcSEcCtD
Nedocromil—Visual impairment—Rivastigmine—Alzheimer's disease	0.00219	0.00575	CcSEcCtD
Nedocromil—Dysgeusia—Donepezil—Alzheimer's disease	0.00218	0.00573	CcSEcCtD
Nedocromil—Tremor—Donepezil—Alzheimer's disease	0.00209	0.00548	CcSEcCtD
Nedocromil—Dyspepsia—Galantamine—Alzheimer's disease	0.00207	0.00542	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00203	0.00532	CcSEcCtD
Nedocromil—Fatigue—Galantamine—Alzheimer's disease	0.00202	0.00531	CcSEcCtD
Nedocromil—Dysgeusia—Memantine—Alzheimer's disease	0.00198	0.0052	CcSEcCtD
Nedocromil—Cough—Donepezil—Alzheimer's disease	0.00194	0.0051	CcSEcCtD
Nedocromil—Dysgeusia—Rivastigmine—Alzheimer's disease	0.00194	0.00509	CcSEcCtD
Nedocromil—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00192	0.00504	CcSEcCtD
Nedocromil—Chest pain—Donepezil—Alzheimer's disease	0.0019	0.00498	CcSEcCtD
Nedocromil—Tremor—Memantine—Alzheimer's disease	0.0019	0.00498	CcSEcCtD
Nedocromil—Dry mouth—Donepezil—Alzheimer's disease	0.00186	0.00487	CcSEcCtD
Nedocromil—Body temperature increased—Galantamine—Alzheimer's disease	0.00186	0.00487	CcSEcCtD
Nedocromil—Abdominal pain—Galantamine—Alzheimer's disease	0.00186	0.00487	CcSEcCtD
Nedocromil—Tremor—Rivastigmine—Alzheimer's disease	0.00185	0.00487	CcSEcCtD
Nedocromil—Leukopenia—Memantine—Alzheimer's disease	0.00181	0.00475	CcSEcCtD
Nedocromil—Cough—Memantine—Alzheimer's disease	0.00177	0.00463	CcSEcCtD
Nedocromil—Hypersensitivity—Galantamine—Alzheimer's disease	0.00173	0.00454	CcSEcCtD
Nedocromil—Cough—Rivastigmine—Alzheimer's disease	0.00173	0.00453	CcSEcCtD
Nedocromil—Chest pain—Memantine—Alzheimer's disease	0.00172	0.00452	CcSEcCtD
Nedocromil—Chest pain—Rivastigmine—Alzheimer's disease	0.00169	0.00442	CcSEcCtD
Nedocromil—Dry mouth—Memantine—Alzheimer's disease	0.00168	0.00442	CcSEcCtD
Nedocromil—Asthenia—Galantamine—Alzheimer's disease	0.00168	0.00442	CcSEcCtD
Nedocromil—Dry mouth—Rivastigmine—Alzheimer's disease	0.00165	0.00433	CcSEcCtD
Nedocromil—Dyspnoea—Donepezil—Alzheimer's disease	0.00162	0.00426	CcSEcCtD
Nedocromil—Diarrhoea—Galantamine—Alzheimer's disease	0.00161	0.00421	CcSEcCtD
Nedocromil—Dyspepsia—Donepezil—Alzheimer's disease	0.0016	0.0042	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00157	0.00412	CcSEcCtD
Nedocromil—Fatigue—Donepezil—Alzheimer's disease	0.00157	0.00412	CcSEcCtD
Nedocromil—Pain—Donepezil—Alzheimer's disease	0.00156	0.00408	CcSEcCtD
Nedocromil—Dizziness—Galantamine—Alzheimer's disease	0.00155	0.00407	CcSEcCtD
Nedocromil—Vomiting—Galantamine—Alzheimer's disease	0.00149	0.00392	CcSEcCtD
Nedocromil—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00149	0.0039	CcSEcCtD
Nedocromil—Rash—Galantamine—Alzheimer's disease	0.00148	0.00388	CcSEcCtD
Nedocromil—Dermatitis—Galantamine—Alzheimer's disease	0.00148	0.00388	CcSEcCtD
Nedocromil—Dyspnoea—Memantine—Alzheimer's disease	0.00147	0.00386	CcSEcCtD
Nedocromil—Headache—Galantamine—Alzheimer's disease	0.00147	0.00386	CcSEcCtD
Nedocromil—Dyspepsia—Memantine—Alzheimer's disease	0.00145	0.00382	CcSEcCtD
Nedocromil—Urticaria—Donepezil—Alzheimer's disease	0.00144	0.00379	CcSEcCtD
Nedocromil—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00144	0.00378	CcSEcCtD
Nedocromil—Abdominal pain—Donepezil—Alzheimer's disease	0.00144	0.00377	CcSEcCtD
Nedocromil—Body temperature increased—Donepezil—Alzheimer's disease	0.00144	0.00377	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00143	0.00374	CcSEcCtD
Nedocromil—Fatigue—Memantine—Alzheimer's disease	0.00142	0.00374	CcSEcCtD
Nedocromil—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00142	0.00373	CcSEcCtD
Nedocromil—Pain—Memantine—Alzheimer's disease	0.00141	0.00371	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00139	0.00366	CcSEcCtD
Nedocromil—Nausea—Galantamine—Alzheimer's disease	0.00139	0.00366	CcSEcCtD
Nedocromil—Fatigue—Rivastigmine—Alzheimer's disease	0.00139	0.00366	CcSEcCtD
Nedocromil—Pain—Rivastigmine—Alzheimer's disease	0.00138	0.00363	CcSEcCtD
Nedocromil—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00135	0.00354	CcSEcCtD
Nedocromil—Hypersensitivity—Donepezil—Alzheimer's disease	0.00134	0.00352	CcSEcCtD
Nedocromil—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00132	0.00347	CcSEcCtD
Nedocromil—Urticaria—Memantine—Alzheimer's disease	0.00131	0.00344	CcSEcCtD
Nedocromil—Body temperature increased—Memantine—Alzheimer's disease	0.00131	0.00343	CcSEcCtD
Nedocromil—Abdominal pain—Memantine—Alzheimer's disease	0.00131	0.00343	CcSEcCtD
Nedocromil—Asthenia—Donepezil—Alzheimer's disease	0.00131	0.00343	CcSEcCtD
Nedocromil—Urticaria—Rivastigmine—Alzheimer's disease	0.00128	0.00337	CcSEcCtD
Nedocromil—Abdominal pain—Rivastigmine—Alzheimer's disease	0.00128	0.00335	CcSEcCtD
Nedocromil—Body temperature increased—Rivastigmine—Alzheimer's disease	0.00128	0.00335	CcSEcCtD
Nedocromil—Diarrhoea—Donepezil—Alzheimer's disease	0.00124	0.00327	CcSEcCtD
Nedocromil—Hypersensitivity—Memantine—Alzheimer's disease	0.00122	0.00319	CcSEcCtD
Nedocromil—Dizziness—Donepezil—Alzheimer's disease	0.0012	0.00316	CcSEcCtD
Nedocromil—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00119	0.00312	CcSEcCtD
Nedocromil—Asthenia—Memantine—Alzheimer's disease	0.00118	0.00311	CcSEcCtD
Nedocromil—Asthenia—Rivastigmine—Alzheimer's disease	0.00116	0.00304	CcSEcCtD
Nedocromil—Vomiting—Donepezil—Alzheimer's disease	0.00116	0.00304	CcSEcCtD
Nedocromil—Rash—Donepezil—Alzheimer's disease	0.00115	0.00301	CcSEcCtD
Nedocromil—Dermatitis—Donepezil—Alzheimer's disease	0.00115	0.00301	CcSEcCtD
Nedocromil—Headache—Donepezil—Alzheimer's disease	0.00114	0.00299	CcSEcCtD
Nedocromil—Diarrhoea—Memantine—Alzheimer's disease	0.00113	0.00297	CcSEcCtD
Nedocromil—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00111	0.0029	CcSEcCtD
Nedocromil—Dizziness—Memantine—Alzheimer's disease	0.00109	0.00287	CcSEcCtD
Nedocromil—Nausea—Donepezil—Alzheimer's disease	0.00108	0.00284	CcSEcCtD
Nedocromil—Dizziness—Rivastigmine—Alzheimer's disease	0.00107	0.0028	CcSEcCtD
Nedocromil—Vomiting—Memantine—Alzheimer's disease	0.00105	0.00276	CcSEcCtD
Nedocromil—Rash—Memantine—Alzheimer's disease	0.00104	0.00273	CcSEcCtD
Nedocromil—Dermatitis—Memantine—Alzheimer's disease	0.00104	0.00273	CcSEcCtD
Nedocromil—Headache—Memantine—Alzheimer's disease	0.00103	0.00272	CcSEcCtD
Nedocromil—Vomiting—Rivastigmine—Alzheimer's disease	0.00103	0.0027	CcSEcCtD
Nedocromil—Rash—Rivastigmine—Alzheimer's disease	0.00102	0.00267	CcSEcCtD
Nedocromil—Dermatitis—Rivastigmine—Alzheimer's disease	0.00102	0.00267	CcSEcCtD
Nedocromil—Headache—Rivastigmine—Alzheimer's disease	0.00101	0.00266	CcSEcCtD
Nedocromil—Nausea—Memantine—Alzheimer's disease	0.000981	0.00257	CcSEcCtD
Nedocromil—Nausea—Rivastigmine—Alzheimer's disease	0.00096	0.00252	CcSEcCtD
Nedocromil—HSP90AA1—Developmental Biology—GSK3B—Alzheimer's disease	0.000126	0.000269	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CCR5—Alzheimer's disease	0.000125	0.000268	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IGF2—Alzheimer's disease	0.000125	0.000267	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—CREB1—Alzheimer's disease	0.000125	0.000267	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—APP—Alzheimer's disease	0.000124	0.000265	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CALM1—Alzheimer's disease	0.000124	0.000265	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—INS—Alzheimer's disease	0.000124	0.000265	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—LEP—Alzheimer's disease	0.000124	0.000264	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—APOE—Alzheimer's disease	0.000124	0.000264	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—ENO1—Alzheimer's disease	0.000123	0.000264	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—LRP1—Alzheimer's disease	0.000123	0.000263	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PPP3CA—Alzheimer's disease	0.000123	0.000262	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CAV1—Alzheimer's disease	0.000123	0.000262	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000123	0.000262	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—ESR1—Alzheimer's disease	0.000122	0.000261	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—AKT1—Alzheimer's disease	0.000121	0.00026	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—IL6—Alzheimer's disease	0.000121	0.000259	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—F2—Alzheimer's disease	0.000121	0.000258	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IGF1R—Alzheimer's disease	0.000121	0.000258	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NPS—Alzheimer's disease	0.00012	0.000257	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GAL—Alzheimer's disease	0.00012	0.000257	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GFAP—Alzheimer's disease	0.00012	0.000257	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PPP3CA—Alzheimer's disease	0.00012	0.000256	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—F2—Alzheimer's disease	0.000118	0.000253	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—NOTCH1—Alzheimer's disease	0.000118	0.000253	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—ESR1—Alzheimer's disease	0.000118	0.000252	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PTK2B—Alzheimer's disease	0.000118	0.000252	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—GAB2—Alzheimer's disease	0.000118	0.000252	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—F2—Alzheimer's disease	0.000117	0.000249	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—GSK3A—Alzheimer's disease	0.000117	0.000249	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—LPL—Alzheimer's disease	0.000116	0.000248	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NTRK2—Alzheimer's disease	0.000115	0.000245	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—GAB2—Alzheimer's disease	0.000115	0.000245	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—SST—Alzheimer's disease	0.000115	0.000245	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MEF2C—Alzheimer's disease	0.000115	0.000245	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—APP—Alzheimer's disease	0.000115	0.000245	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CALM1—Alzheimer's disease	0.000114	0.000244	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—NOTCH1—Alzheimer's disease	0.000114	0.000244	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—GSK3A—Alzheimer's disease	0.000114	0.000243	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PRKCG—Alzheimer's disease	0.000113	0.000241	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—APP—Alzheimer's disease	0.000112	0.000239	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—AKT1—Alzheimer's disease	0.000112	0.000239	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—GSK3B—Alzheimer's disease	0.000111	0.000237	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—GSK3B—Alzheimer's disease	0.000111	0.000237	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ACHE—Alzheimer's disease	0.00011	0.000236	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CREB1—Alzheimer's disease	0.00011	0.000236	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CREB1—Alzheimer's disease	0.00011	0.000235	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—VEGFA—Alzheimer's disease	0.00011	0.000235	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—NGF—Alzheimer's disease	0.00011	0.000234	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—INS—Alzheimer's disease	0.000109	0.000234	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—INPP5D—Alzheimer's disease	0.000109	0.000233	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CCL2—Alzheimer's disease	0.000108	0.00023	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—F2—Alzheimer's disease	0.000107	0.00023	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—GSK3B—Alzheimer's disease	0.000107	0.000229	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCR5—Alzheimer's disease	0.000107	0.000228	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CREB1—Alzheimer's disease	0.000106	0.000227	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—A2M—Alzheimer's disease	0.000106	0.000226	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IGF1—Alzheimer's disease	0.000106	0.000226	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—INS—Alzheimer's disease	0.000106	0.000226	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PLCB1—Alzheimer's disease	0.000106	0.000226	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—HTR2A—Alzheimer's disease	0.000104	0.000223	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CCL2—Alzheimer's disease	0.000104	0.000222	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PTGS1—Alzheimer's disease	0.000103	0.000221	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ENO1—Alzheimer's disease	0.000103	0.000221	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PSEN2—Alzheimer's disease	0.000103	0.000219	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IGF1—Alzheimer's disease	0.000102	0.000219	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CYP2D6—Alzheimer's disease	0.000101	0.000217	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—S100B—Alzheimer's disease	0.000101	0.000216	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—ADAM10—Alzheimer's disease	9.86e-05	0.000211	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NGFR—Alzheimer's disease	9.85e-05	0.000211	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CREB1—Alzheimer's disease	9.78e-05	0.000209	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—TP53—Alzheimer's disease	9.78e-05	0.000209	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CALM1—Alzheimer's disease	9.74e-05	0.000208	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—LEP—Alzheimer's disease	9.71e-05	0.000208	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—APOE—Alzheimer's disease	9.71e-05	0.000208	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—ADAM10—Alzheimer's disease	9.62e-05	0.000206	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CAV1—Alzheimer's disease	9.62e-05	0.000206	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—BCHE—Alzheimer's disease	9.6e-05	0.000205	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—NOS3—Alzheimer's disease	9.59e-05	0.000205	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CCL2—Alzheimer's disease	9.57e-05	0.000205	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NPY—Alzheimer's disease	9.44e-05	0.000202	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IAPP—Alzheimer's disease	9.38e-05	0.000201	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—ESR1—Alzheimer's disease	9.27e-05	0.000198	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—NOS3—Alzheimer's disease	9.27e-05	0.000198	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—BCL2—Alzheimer's disease	9.25e-05	0.000198	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—F2—Alzheimer's disease	9.15e-05	0.000196	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL1A—Alzheimer's disease	9.13e-05	0.000195	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CRH—Alzheimer's disease	9.11e-05	0.000195	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—S100B—Alzheimer's disease	9.09e-05	0.000194	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PLCB1—Alzheimer's disease	9.06e-05	0.000194	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—NOTCH1—Alzheimer's disease	8.96e-05	0.000192	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—IL6—Alzheimer's disease	8.95e-05	0.000191	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—MEF2C—Alzheimer's disease	8.83e-05	0.000189	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ABCA1—Alzheimer's disease	8.78e-05	0.000188	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—AGER—Alzheimer's disease	8.75e-05	0.000187	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PRKCG—Alzheimer's disease	8.66e-05	0.000185	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IGF2—Alzheimer's disease	8.66e-05	0.000185	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NPS—Alzheimer's disease	8.63e-05	0.000185	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PPP3CA—Alzheimer's disease	8.59e-05	0.000184	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PTK2B—Alzheimer's disease	8.47e-05	0.000181	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—GSK3B—Alzheimer's disease	8.41e-05	0.00018	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IGF1R—Alzheimer's disease	8.37e-05	0.000179	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CREB1—Alzheimer's disease	8.34e-05	0.000178	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—INS—Alzheimer's disease	8.29e-05	0.000177	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SST—Alzheimer's disease	8.24e-05	0.000176	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NTRK2—Alzheimer's disease	8.24e-05	0.000176	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GAB2—Alzheimer's disease	8.24e-05	0.000176	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—LPL—Alzheimer's disease	8.23e-05	0.000176	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—AKT1—Alzheimer's disease	8.22e-05	0.000176	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GSK3A—Alzheimer's disease	8.17e-05	0.000175	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCL2—Alzheimer's disease	8.16e-05	0.000174	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CASP3—Alzheimer's disease	8.15e-05	0.000174	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—IL6—Alzheimer's disease	8.09e-05	0.000173	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—APP—Alzheimer's disease	8.03e-05	0.000172	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—LPL—Alzheimer's disease	8.03e-05	0.000172	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IGF1—Alzheimer's disease	8.02e-05	0.000171	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PRKCG—Alzheimer's disease	8e-05	0.000171	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MEF2C—Alzheimer's disease	7.95e-05	0.00017	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—AKT1—Alzheimer's disease	7.94e-05	0.00017	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CASP3—Alzheimer's disease	7.87e-05	0.000168	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—VEGFA—Alzheimer's disease	7.84e-05	0.000168	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—IL6—Alzheimer's disease	7.82e-05	0.000167	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PRKCG—Alzheimer's disease	7.8e-05	0.000167	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NGF—Alzheimer's disease	7.6e-05	0.000163	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—IL6—Alzheimer's disease	7.6e-05	0.000162	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CCR5—Alzheimer's disease	7.58e-05	0.000162	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PLCB1—Alzheimer's disease	7.57e-05	0.000162	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PPARGC1A—Alzheimer's disease	7.57e-05	0.000162	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—HMOX1—Alzheimer's disease	7.53e-05	0.000161	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—MAPK8—Alzheimer's disease	7.5e-05	0.00016	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CALM1—Alzheimer's disease	7.5e-05	0.00016	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MAPK8—Alzheimer's disease	7.49e-05	0.00016	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—AKT1—Alzheimer's disease	7.47e-05	0.00016	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MTHFR—Alzheimer's disease	7.41e-05	0.000158	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCR5—Alzheimer's disease	7.39e-05	0.000158	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—NOS3—Alzheimer's disease	7.27e-05	0.000155	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HTR2A—Alzheimer's disease	7.24e-05	0.000155	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MAPK8—Alzheimer's disease	7.23e-05	0.000155	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—AKT1—Alzheimer's disease	7.21e-05	0.000154	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—TGFB1—Alzheimer's disease	7.19e-05	0.000154	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NGFR—Alzheimer's disease	7.07e-05	0.000151	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CALM1—Alzheimer's disease	6.92e-05	0.000148	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—VEGFA—Alzheimer's disease	6.91e-05	0.000148	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ADAM10—Alzheimer's disease	6.9e-05	0.000148	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—APOE—Alzheimer's disease	6.9e-05	0.000147	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—LPL—Alzheimer's disease	6.89e-05	0.000147	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CAV1—Alzheimer's disease	6.83e-05	0.000146	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CALM1—Alzheimer's disease	6.75e-05	0.000144	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—LEP—Alzheimer's disease	6.73e-05	0.000144	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—APOE—Alzheimer's disease	6.73e-05	0.000144	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—TNF—Alzheimer's disease	6.72e-05	0.000144	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—VEGFA—Alzheimer's disease	6.68e-05	0.000143	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CAV1—Alzheimer's disease	6.67e-05	0.000143	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—S100B—Alzheimer's disease	6.53e-05	0.00014	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—GSK3B—Alzheimer's disease	6.47e-05	0.000138	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NOS2—Alzheimer's disease	6.43e-05	0.000137	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—ESR1—Alzheimer's disease	6.42e-05	0.000137	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CREB1—Alzheimer's disease	6.42e-05	0.000137	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NOTCH1—Alzheimer's disease	6.36e-05	0.000136	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—F2—Alzheimer's disease	6.34e-05	0.000136	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TGFB1—Alzheimer's disease	6.34e-05	0.000136	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—AKT1—Alzheimer's disease	6.23e-05	0.000133	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IGF2—Alzheimer's disease	6.22e-05	0.000133	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NOTCH1—Alzheimer's disease	6.21e-05	0.000133	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—MTHFR—Alzheimer's disease	6.2e-05	0.000133	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CASP3—Alzheimer's disease	6.17e-05	0.000132	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—IL6—Alzheimer's disease	6.13e-05	0.000131	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TGFB1—Alzheimer's disease	6.13e-05	0.000131	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IGF1R—Alzheimer's disease	6.01e-05	0.000128	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—GSK3B—Alzheimer's disease	5.97e-05	0.000128	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CREB1—Alzheimer's disease	5.92e-05	0.000127	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—INS—Alzheimer's disease	5.89e-05	0.000126	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—GSK3B—Alzheimer's disease	5.83e-05	0.000125	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CALM1—Alzheimer's disease	5.8e-05	0.000124	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CREB1—Alzheimer's disease	5.78e-05	0.000124	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—APOE—Alzheimer's disease	5.78e-05	0.000123	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—LPL—Alzheimer's disease	5.76e-05	0.000123	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—INS—Alzheimer's disease	5.75e-05	0.000123	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CAV1—Alzheimer's disease	5.72e-05	0.000122	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MEF2C—Alzheimer's disease	5.71e-05	0.000122	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MAPK8—Alzheimer's disease	5.67e-05	0.000121	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—AKT1—Alzheimer's disease	5.66e-05	0.000121	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCL2—Alzheimer's disease	5.65e-05	0.000121	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PRKCG—Alzheimer's disease	5.6e-05	0.00012	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IGF1—Alzheimer's disease	5.56e-05	0.000119	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—TP53—Alzheimer's disease	5.48e-05	0.000117	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NGF—Alzheimer's disease	5.46e-05	0.000117	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—IL6—Alzheimer's disease	5.42e-05	0.000116	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—BCL2—Alzheimer's disease	5.39e-05	0.000115	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCR5—Alzheimer's disease	5.31e-05	0.000113	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—VEGFA—Alzheimer's disease	5.24e-05	0.000112	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TP53—Alzheimer's disease	5.22e-05	0.000112	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HTR2A—Alzheimer's disease	5.19e-05	0.000111	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NOS3—Alzheimer's disease	5.17e-05	0.00011	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TP53—Alzheimer's disease	5.04e-05	0.000108	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NOS3—Alzheimer's disease	5.04e-05	0.000108	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PPARG—Alzheimer's disease	5.03e-05	0.000108	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—AKT1—Alzheimer's disease	5e-05	0.000107	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—INS—Alzheimer's disease	4.93e-05	0.000105	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CALM1—Alzheimer's disease	4.85e-05	0.000104	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—LEP—Alzheimer's disease	4.83e-05	0.000103	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—APOE—Alzheimer's disease	4.83e-05	0.000103	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TGFB1—Alzheimer's disease	4.81e-05	0.000103	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—IL6—Alzheimer's disease	4.79e-05	0.000102	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CAV1—Alzheimer's disease	4.78e-05	0.000102	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IL6—Alzheimer's disease	4.78e-05	0.000102	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL1B—Alzheimer's disease	4.76e-05	0.000102	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PTGS2—Alzheimer's disease	4.73e-05	0.000101	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IL6—Alzheimer's disease	4.62e-05	9.87e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ESR1—Alzheimer's disease	4.61e-05	9.86e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—F2—Alzheimer's disease	4.55e-05	9.74e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NOTCH1—Alzheimer's disease	4.46e-05	9.53e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—AKT1—Alzheimer's disease	4.42e-05	9.44e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—AKT1—Alzheimer's disease	4.41e-05	9.43e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—MAPK8—Alzheimer's disease	4.37e-05	9.34e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—NOS3—Alzheimer's disease	4.33e-05	9.25e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—AKT1—Alzheimer's disease	4.32e-05	9.23e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CASP3—Alzheimer's disease	4.28e-05	9.15e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—AKT1—Alzheimer's disease	4.26e-05	9.11e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—IL6—Alzheimer's disease	4.25e-05	9.09e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GSK3B—Alzheimer's disease	4.18e-05	8.94e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CREB1—Alzheimer's disease	4.15e-05	8.87e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—INS—Alzheimer's disease	4.13e-05	8.82e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCL2—Alzheimer's disease	4.06e-05	8.68e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IGF1—Alzheimer's disease	3.99e-05	8.53e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TP53—Alzheimer's disease	3.96e-05	8.46e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PTGS2—Alzheimer's disease	3.96e-05	8.46e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MAPK8—Alzheimer's disease	3.93e-05	8.41e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—AKT1—Alzheimer's disease	3.92e-05	8.39e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—VEGFA—Alzheimer's disease	3.63e-05	7.76e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IL6—Alzheimer's disease	3.62e-05	7.75e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NOS3—Alzheimer's disease	3.62e-05	7.74e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—TGFB1—Alzheimer's disease	3.42e-05	7.3e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—AKT1—Alzheimer's disease	3.34e-05	7.15e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TGFB1—Alzheimer's disease	3.33e-05	7.13e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CASP3—Alzheimer's disease	3.07e-05	6.57e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MAPK8—Alzheimer's disease	2.82e-05	6.04e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL6—Alzheimer's disease	2.79e-05	5.96e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TP53—Alzheimer's disease	2.74e-05	5.87e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—VEGFA—Alzheimer's disease	2.61e-05	5.57e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—IL6—Alzheimer's disease	2.57e-05	5.5e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—AKT1—Alzheimer's disease	2.57e-05	5.5e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IL6—Alzheimer's disease	2.51e-05	5.37e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TGFB1—Alzheimer's disease	2.39e-05	5.11e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—AKT1—Alzheimer's disease	2.37e-05	5.08e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—AKT1—Alzheimer's disease	2.32e-05	4.95e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—AKT1—Alzheimer's disease	1.99e-05	4.25e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TP53—Alzheimer's disease	1.97e-05	4.21e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IL6—Alzheimer's disease	1.8e-05	3.85e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—AKT1—Alzheimer's disease	1.66e-05	3.56e-05	CbGpPWpGaD
